Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Candela, a developer of new technologies for light-based aesthetic therapies, has received Health Canada approval for its new QuadraLASE advanced CO2 fractional laser for distribution in Canada.
Subscribe to our email newsletter
With a unique combination of the performance of a CO2 laser and a scanning device, the QuadraLASE is an effective solution for aesthetic treatments such as skin rejuvenation, skin tightening/wrinkle reduction, uneven tone and texture, and acne scarring, the company said.
According to Candela, the new QuadraLASE fractional laser features QuadraSCAN technology, which reduces heat build-up in the skin, resulting in increased patient comfort. Candela QuadraLASE offers performance, versatility and value in a fractional CO2 laser.
Gerard Puorro, president and CEO of Candela, said: “Candela’s customers in the US, Europe and Australia are looking at fractional CO2 in a new way and embracing the QuadraLASE as a total rejuvenation system. In addition, they are reporting that the QuadraLASE is a great option for patients who want fast results and better looking skin without the need for multiple treatments.”